The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study

References

• Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712–721.e4.
   PubMed Web of Science ®Google Scholar
• El-Salhy M. Irritable bowel syndrome: diagnosis and pathogenesis. World J Gastroenterol. 2012;18(37):5151–5163.
   PubMed Web of Science ®Google Scholar
• Enck P, Aziz Q, Barbara G, et al. Irritable bowel syndrome. Nat Rev Dis Prim. 2016;2:1–24.
   Web of Science ®Google Scholar
• Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393–1407.e5.
   Web of Science ®Google Scholar
• Gralnek IM, Hays RD, Kilbourne AA, et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119(3):654–660.
   PubMed Web of Science ®Google Scholar
• Amouretti M, Le Pen C, Gaudin AF, et al. Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL). Gastroenterol Clin Biol. 2006;30(2):241–246.
   PubMedGoogle Scholar
• Inadomi JM, Fennerty MB, Bjorkman D. Systematic review: the economic impact of irritable bowel syndrome. Aliment Pharmacol Ther. 2003;18(7):671–682.
   PubMed Web of Science ®Google Scholar
• Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2016;1(2):133–146.
   PubMed Web of Science ®Google Scholar
• Ianiro G, Eusebi LH, Black CJ, et al. Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 2019;50(3):240–248.
   PubMed Web of Science ®Google Scholar
• Halkjaer SI, Christensen AH, Lo BZS, et al. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Gut. 2018;67(12):2107–2115.
   PubMed Web of Science ®Google Scholar
• Xu D, Chen VL, Steiner CA, et al. Efficacy of fecal microbiota transplantation in irritable bowel syndrome: a systematic review and meta-analysis. Am J Gastroenterol. 2019;114(7):1043–1050.
   PubMed Web of Science ®Google Scholar
• Hadjivasilis A, Tsioutis C, Michalinos A, et al. New insights into irritable bowel syndrome: from pathophysiology to treatment. Ann Gastroenterol. 2019;32(6):554–564.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Choi JK, Ryu HS, et al. Therapeutic modulation of gut microbiota in functional bowel disorders. J Neurogastroenterol Motil. 2017;23(1):9–19.
   PubMed Web of Science ®Google Scholar
• Quraishi MN, Widlak M, Bhala N, et al. Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection. Aliment Pharmacol Ther. 2017;46(5):479–493.
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Committee for Medicinal Products for Human use. Guideline on the evaluation of medicinal products for the treatment of irritable bowel syndrome [Internet]. 2014. [cited 2020 Oct 1]. Available from: https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-evaluation-medicinal-products-treatment-irritable-bowel-syndrome-revision-1_en.pdf.
   Google Scholar
• U.S. Department of Health and Human Services. Food and Drug Administration. Center for Drug Evaluation and Research. Guidance for industry irritable bowel syndrome-clinical evaluation of drugs for treatment [Internet]. 2012. [cited 2020 Oct 1]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/irritable-bowel-syndrome-clinical-evaluation-products-treatment.
   Google Scholar
• Kelly CR, Kunde SS, Khoruts A. Guidance on preparing an investigational new drug application for fecal microbiota transplantation studies. Clin Gastroenterol Hepatol. 2014;12(2):283–288.
   PubMed Web of Science ®Google Scholar
• Blake MR, Raker JM, Whelan K. Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2016;44(7):693–703.
   PubMed Web of Science ®Google Scholar
• Heaton KW, Radvan J, Cripps H, et al. Defecation frequency and timing, and stool form in the general population: A prospective study. Gut. 1992;33(6):818–824.
   PubMed Web of Science ®Google Scholar
• Maria R, et al. Modulation of the gut microbiome by oral intake of a synbiotic mixture in healthy volunteers: a single center, one-armed pilot study. Unpublished data. 2021.
   Google Scholar
• Team R Development Core. A language and environment for statistical computing [Internet]. Vol. 2. Vienna: R Foundation for Statistical Computing; 2018. Available from: http://www.r-project.org
   Google Scholar
• Holvoet T, Joossens M, Vázquez-Castellanos JF, et al. Fecal microbiota transplantation reduces symptoms in some patients with irritable bowel syndrome with predominant abdominal bloating: short- and long-term results from a placebo-controlled randomized trial. Gastroenterology. 2021;160(1):145–113. (October):Available from:
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Hatlebakk JG, Gilja OH, et al. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut. 2020;69(5):859–867.
   PubMed Web of Science ®Google Scholar
• Johnsen PH, Hilpüsch F, Cavanagh JP, et al. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol. 2018;3(1):17–24.
   PubMed Web of Science ®Google Scholar
• Holster S, Brummer RJ, Repsilber D, et al. Fecal microbiota transplantation in irritable bowel syndrome and a randomized placebo-controlled trial. Gastroenterology. 2017;152(5):S101–S2.
   Web of Science ®Google Scholar
• Lahtinen P, Jalanka J, Hartikainen A, et al. Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome. Aliment Pharmacol Ther. 2020;51(12):1321–1331.
   PubMed Web of Science ®Google Scholar
• Aroniadis OC, Brandt LJ, Oneto C, et al. Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. Lancet Gastroenterol Hepatol. 2019;4(9):675–685.
   PubMed Web of Science ®Google Scholar
• Patel SM, Stason WB, Legedza A, et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil. 2005; Jun17(3):332–340.
   PubMed Web of Science ®Google Scholar
• Shah E, Pimentel M. Placebo effect in clinical trial design for irritable bowel syndrome. J Neurogastroenterol Motil. 2014;20(2):163–170.
   PubMed Web of Science ®Google Scholar